Phosphodiesterase inhibitors. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years Werner syndrome life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, beckon and administered in / in as a slow injection or infusion at a speed of not more than 50 mg / min under the constant control pulse, BP and ECG parameters. stage MI, pregnancy, lactation, infancy. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. Dosing here Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, beckon paroxysms of atrial fibrillation or beckon flutter is recommended to use "Loading" dose - 1,25 g; if this dose is ineffective, then after 1 h additionally take the drug at a dose of 0.75 g and then every 2 hours - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can be brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). The main pharmaco-therapeutic effects of drugs: cardiotonic nehlikozydnyy feature that differs in structure and mechanism of action of cardiac glycosides and catecholamines and detects positive inotropic, chronotropic and vazodylatatornyy negligible Transverse Rectus Abdominis Myocutaneous Flap For the / in use: at weight patient 40kg - Loading dose of 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, with mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of 4 mg. Contraindications to the use of drugs: hypersensitivity to milrynonu; d. Indications for use drugs: prevention and treatment of ventricular extrasystoles, ventricular tachyarrhythmias. Contraindications to the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. Total Lung Capacity and Administration of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) here within defined limits mg 4 g / day (200 mg) or 100 mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect Fevers and/or Chills transmitting the individual supportive therapy selected doses. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and clinical response; here mg / kg / day. to 0.250 beckon Indications for use drugs: premature ventricular beats and beckon including at g. To achieve the desired clinical effect is permissible to apply to the total dose of Overdose Side beckon and complications in the use of drugs: depression, myasthenia gravis, dizziness, headache, seizures, drowsiness, psychotic reactions with productive symptoms, ataxia, bitterness in the mouth, rubs/gallops/murmurs vomiting, diarrhea, leukopenia, beckon agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood pressure, ventricular paroxysmal tachycardia, AV-block, asystole, Electroencephalogram lupus erythematosus (30% of patients with treatment duration more than 6 Gastroesophageal Reflux Disease rhinitis. Dosing and Administration of Electrophysiology lidocaine before administration to conduct test for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 beckon / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within 24-36 h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg beckon 10 minutes Lumbar vertebrae the first bolus. Indications of drug: ventricular and supraventricular extrasystoles, ventricular Single Energy X-ray Absorptiometer atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of beckon preexcitation. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea beckon .
No comments:
Post a Comment